Pathologists at one of England's most innovative trusts have chosen the CliniSys laboratory information system (LIMS) as part of a digital strategy to support its drive to continually improve patient care.
The pathology team at Northumbria Healthcare NHS Foundation Trust has decided to replace their legacy LIMS with WinPath Enterprise, hosted by CliniSys from its UK data centre.
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle's Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the introduction of the Roche Digital Pathology Open Environment that allows software developers to easily integrate their image analysis tools for tumour tissue with Roche's uPath enterprise software, an application for pathologist workflow. This open environment allows for the secure exchange and flow of data so that pathologists can access advanced algorithms from third parties alongside Roche's menu of artificial intelligence-based image analysis tools.
The research was sparked by the pandemic and set out to build an AI tool to predict how much extra oxygen a COVID-19 patient may need in the first days of hospital care, using data from across four continents.
Telehealth and telemedicine emerged as essential communications tools during the COVID-19 pandemic as alternatives to face-to-face consultation between patients and physicians.
15 - 18 November 2021, Düsseldorf, Germany.| Location: | Berlin, Germany |
| Job Type: | Full-Time |
| Employer: | Bayer |
Through a year-long collaboration with a number of leading healthcare institutions across the globe, Siemens Healthineers has developed the Atellica COVID-19 Severity Algorithm,(1) a model designed to help predict the potential liklihood of progression to severe disease and life-threatening multiorgan dysfunction in COVID-19 patients.